•
Mar 31, 2017

Jazz Pharmaceuticals Q1 2017 Earnings Report

Total Revenue
$376M
Previous year: $336M
+11.9%
EPS
$2.31
Previous year: $2.26
+2.2%
Gross Profit
$351M
Previous year: $313M
+12.3%
Cash and Equivalents
$347M
Previous year: $980M
-64.6%
Total Assets
$4.82B
Previous year: $3.53B
+36.2%

Jazz Pharmaceuticals

Jazz Pharmaceuticals